Etiometry Inc., a medical technology company which developed a critical care digital twin analytics platform, announced today the recent expansion of their leadership team.
Shane Cooke, was recently appointed as President and Chief Executive Officer, joining the growing company as it continues to expand its presence in current and new markets. Cooke brings more than 19 years of experience in the medical device and pharmaceutical market spaces in a variety of sales, marketing, strategy, and portfolio management roles. Before joining Etiometry, Cooke spent more than five years as Chief Strategy Officer of Cheetah Medical, which was recently acquired.
“I am excited to join Etiometry, whose best-in-class technology is already utilized in top pediatric hospitals throughout the world” said Cooke. “This technology platform has massive market potential, and I look forward to accelerating growth and realizing the company’s vision of improving outcomes and avoiding patient harm.”
In recent months, Etiometry also expanded their Board of Directors to include Guy Lyndon Fish MD, Gregory S. Martin, CEO and President of Shamrock Holdings, and David Shepherd, co-CEO of Shepherd Kaplan Krochuk.
Former Etiometry CEO and Co-founder, Evan Butler, is taking on a new role as Chief Operating Officer.
Based in Boston, Etiometry provides next-generation patient monitoring software for hospital ICUs. By consolidating data from many ICU devices, the Etiometry Platform helps clinicians better understand the trajectory of their patients by viewing salient clinical information on a single screen. It fosters more objective communication among care teams and provides a common platform to analyze the best course of treatment for ICU patients. For more information, visit www.etiometry.com.